Valley Fever Medication Market, Global Outlook and Forecast 2022-2028

August 2022 | 64 pages | ID: V8F78FB7B8DBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Valley Fever Medication in Global, including the following market information:

Global Valley Fever Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Valley Fever Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fluconazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Valley Fever Medication include Pfizer, Bayer, Teva Pharmaceuticals, Apotex, Sanofi-Aventis, Hexal, Mylan, Baxter and Lunan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Valley Fever Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Valley Fever Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Valley Fever Medication Market Segment Percentages, by Type, 2021 (%)

• Fluconazole
• Voriconazole
• Posaconazole
• Amphotericin B
• Others

Global Valley Fever Medication Market, by Channel, 2017-2022, 2023-2028 ($ millions)

Global Valley Fever Medication Market Segment Percentages, by Channel, 2021 (%)

• Hospital
• Retail
• Others

Global Valley Fever Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Valley Fever Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Valley Fever Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Valley Fever Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Bayer
• Teva Pharmaceuticals
• Apotex
• Sanofi-Aventis
• Hexal
• Mylan
• Baxter
• Lunan Pharmaceutical
• Yi Kang Pharm
• Kelun
• ShiJiaZhuang No.4 Pharmaceutical
• Qilu Pharmaceutical Group
• Minsheng Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Valley Fever Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Channel
1.3 Global Valley Fever Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VALLEY FEVER MEDICATION OVERALL MARKET SIZE

2.1 Global Valley Fever Medication Market Size: 2021 VS 2028
2.2 Global Valley Fever Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Valley Fever Medication Players in Global Market
3.2 Top Global Valley Fever Medication Companies Ranked by Revenue
3.3 Global Valley Fever Medication Revenue by Companies
3.4 Top 3 and Top 5 Valley Fever Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies Valley Fever Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Valley Fever Medication Players in Global Market
  3.6.1 List of Global Tier 1 Valley Fever Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Valley Fever Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Valley Fever Medication Market Size Markets, 2021 & 2028
  4.1.2 Fluconazole
  4.1.3 Voriconazole
  4.1.4 Posaconazole
  4.1.5 Amphotericin B
  4.1.6 Others
4.2 By Type - Global Valley Fever Medication Revenue & Forecasts
  4.2.1 By Type - Global Valley Fever Medication Revenue, 2017-2022
  4.2.2 By Type - Global Valley Fever Medication Revenue, 2023-2028
  4.2.3 By Type - Global Valley Fever Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Valley Fever Medication Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail
  5.1.4 Others
5.2 By Channel - Global Valley Fever Medication Revenue & Forecasts
  5.2.1 By Channel - Global Valley Fever Medication Revenue, 2017-2022
  5.2.2 By Channel - Global Valley Fever Medication Revenue, 2023-2028
  5.2.3 By Channel - Global Valley Fever Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Valley Fever Medication Market Size, 2021 & 2028
6.2 By Region - Global Valley Fever Medication Revenue & Forecasts
  6.2.1 By Region - Global Valley Fever Medication Revenue, 2017-2022
  6.2.2 By Region - Global Valley Fever Medication Revenue, 2023-2028
  6.2.3 By Region - Global Valley Fever Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Valley Fever Medication Revenue, 2017-2028
  6.3.2 US Valley Fever Medication Market Size, 2017-2028
  6.3.3 Canada Valley Fever Medication Market Size, 2017-2028
  6.3.4 Mexico Valley Fever Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Valley Fever Medication Revenue, 2017-2028
  6.4.2 Germany Valley Fever Medication Market Size, 2017-2028
  6.4.3 France Valley Fever Medication Market Size, 2017-2028
  6.4.4 U.K. Valley Fever Medication Market Size, 2017-2028
  6.4.5 Italy Valley Fever Medication Market Size, 2017-2028
  6.4.6 Russia Valley Fever Medication Market Size, 2017-2028
  6.4.7 Nordic Countries Valley Fever Medication Market Size, 2017-2028
  6.4.8 Benelux Valley Fever Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Valley Fever Medication Revenue, 2017-2028
  6.5.2 China Valley Fever Medication Market Size, 2017-2028
  6.5.3 Japan Valley Fever Medication Market Size, 2017-2028
  6.5.4 South Korea Valley Fever Medication Market Size, 2017-2028
  6.5.5 Southeast Asia Valley Fever Medication Market Size, 2017-2028
  6.5.6 India Valley Fever Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Valley Fever Medication Revenue, 2017-2028
  6.6.2 Brazil Valley Fever Medication Market Size, 2017-2028
  6.6.3 Argentina Valley Fever Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Valley Fever Medication Revenue, 2017-2028
  6.7.2 Turkey Valley Fever Medication Market Size, 2017-2028
  6.7.3 Israel Valley Fever Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia Valley Fever Medication Market Size, 2017-2028
  6.7.5 UAE Valley Fever Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Valley Fever Medication Major Product Offerings
  7.1.4 Pfizer Valley Fever Medication Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Valley Fever Medication Major Product Offerings
  7.2.4 Bayer Valley Fever Medication Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Teva Pharmaceuticals
  7.3.1 Teva Pharmaceuticals Corporate Summary
  7.3.2 Teva Pharmaceuticals Business Overview
  7.3.3 Teva Pharmaceuticals Valley Fever Medication Major Product Offerings
  7.3.4 Teva Pharmaceuticals Valley Fever Medication Revenue in Global Market (2017-2022)
  7.3.5 Teva Pharmaceuticals Key News
7.4 Apotex
  7.4.1 Apotex Corporate Summary
  7.4.2 Apotex Business Overview
  7.4.3 Apotex Valley Fever Medication Major Product Offerings
  7.4.4 Apotex Valley Fever Medication Revenue in Global Market (2017-2022)
  7.4.5 Apotex Key News
7.5 Sanofi-Aventis
  7.5.1 Sanofi-Aventis Corporate Summary
  7.5.2 Sanofi-Aventis Business Overview
  7.5.3 Sanofi-Aventis Valley Fever Medication Major Product Offerings
  7.5.4 Sanofi-Aventis Valley Fever Medication Revenue in Global Market (2017-2022)
  7.5.5 Sanofi-Aventis Key News
7.6 Hexal
  7.6.1 Hexal Corporate Summary
  7.6.2 Hexal Business Overview
  7.6.3 Hexal Valley Fever Medication Major Product Offerings
  7.6.4 Hexal Valley Fever Medication Revenue in Global Market (2017-2022)
  7.6.5 Hexal Key News
7.7 Mylan
  7.7.1 Mylan Corporate Summary
  7.7.2 Mylan Business Overview
  7.7.3 Mylan Valley Fever Medication Major Product Offerings
  7.7.4 Mylan Valley Fever Medication Revenue in Global Market (2017-2022)
  7.7.5 Mylan Key News
7.8 Baxter
  7.8.1 Baxter Corporate Summary
  7.8.2 Baxter Business Overview
  7.8.3 Baxter Valley Fever Medication Major Product Offerings
  7.8.4 Baxter Valley Fever Medication Revenue in Global Market (2017-2022)
  7.8.5 Baxter Key News
7.9 Lunan Pharmaceutical
  7.9.1 Lunan Pharmaceutical Corporate Summary
  7.9.2 Lunan Pharmaceutical Business Overview
  7.9.3 Lunan Pharmaceutical Valley Fever Medication Major Product Offerings
  7.9.4 Lunan Pharmaceutical Valley Fever Medication Revenue in Global Market (2017-2022)
  7.9.5 Lunan Pharmaceutical Key News
7.10 Yi Kang Pharm
  7.10.1 Yi Kang Pharm Corporate Summary
  7.10.2 Yi Kang Pharm Business Overview
  7.10.3 Yi Kang Pharm Valley Fever Medication Major Product Offerings
  7.10.4 Yi Kang Pharm Valley Fever Medication Revenue in Global Market (2017-2022)
  7.10.5 Yi Kang Pharm Key News
7.11 Kelun
  7.11.1 Kelun Corporate Summary
  7.11.2 Kelun Business Overview
  7.11.3 Kelun Valley Fever Medication Major Product Offerings
  7.11.4 Kelun Valley Fever Medication Revenue in Global Market (2017-2022)
  7.11.5 Kelun Key News
7.12 ShiJiaZhuang No.4 Pharmaceutical
  7.12.1 ShiJiaZhuang No.4 Pharmaceutical Corporate Summary
  7.12.2 ShiJiaZhuang No.4 Pharmaceutical Business Overview
  7.12.3 ShiJiaZhuang No.4 Pharmaceutical Valley Fever Medication Major Product Offerings
  7.12.4 ShiJiaZhuang No.4 Pharmaceutical Valley Fever Medication Revenue in Global Market (2017-2022)
  7.12.5 ShiJiaZhuang No.4 Pharmaceutical Key News
7.13 Qilu Pharmaceutical Group
  7.13.1 Qilu Pharmaceutical Group Corporate Summary
  7.13.2 Qilu Pharmaceutical Group Business Overview
  7.13.3 Qilu Pharmaceutical Group Valley Fever Medication Major Product Offerings
  7.13.4 Qilu Pharmaceutical Group Valley Fever Medication Revenue in Global Market (2017-2022)
  7.13.5 Qilu Pharmaceutical Group Key News
7.14 Minsheng Pharmaceutical
  7.14.1 Minsheng Pharmaceutical Corporate Summary
  7.14.2 Minsheng Pharmaceutical Business Overview
  7.14.3 Minsheng Pharmaceutical Valley Fever Medication Major Product Offerings
  7.14.4 Minsheng Pharmaceutical Valley Fever Medication Revenue in Global Market (2017-2022)
  7.14.5 Minsheng Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Valley Fever Medication Market Opportunities & Trends in Global Market
Table 2. Valley Fever Medication Market Drivers in Global Market
Table 3. Valley Fever Medication Market Restraints in Global Market
Table 4. Key Players of Valley Fever Medication in Global Market
Table 5. Top Valley Fever Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Valley Fever Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Valley Fever Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies Valley Fever Medication Product Type
Table 9. List of Global Tier 1 Valley Fever Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Valley Fever Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Valley Fever Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Valley Fever Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Valley Fever Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Channel – Global Valley Fever Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Channel - Valley Fever Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Channel - Valley Fever Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Valley Fever Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Valley Fever Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Valley Fever Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Valley Fever Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Valley Fever Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Valley Fever Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Valley Fever Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Valley Fever Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Valley Fever Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Valley Fever Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Valley Fever Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Valley Fever Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Valley Fever Medication Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Valley Fever Medication Product Offerings
Table 32. Pfizer Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Valley Fever Medication Product Offerings
Table 35. Bayer Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceuticals Corporate Summary
Table 37. Teva Pharmaceuticals Valley Fever Medication Product Offerings
Table 38. Teva Pharmaceuticals Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 39. Apotex Corporate Summary
Table 40. Apotex Valley Fever Medication Product Offerings
Table 41. Apotex Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi-Aventis Corporate Summary
Table 43. Sanofi-Aventis Valley Fever Medication Product Offerings
Table 44. Sanofi-Aventis Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 45. Hexal Corporate Summary
Table 46. Hexal Valley Fever Medication Product Offerings
Table 47. Hexal Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 48. Mylan Corporate Summary
Table 49. Mylan Valley Fever Medication Product Offerings
Table 50. Mylan Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 51. Baxter Corporate Summary
Table 52. Baxter Valley Fever Medication Product Offerings
Table 53. Baxter Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 54. Lunan Pharmaceutical Corporate Summary
Table 55. Lunan Pharmaceutical Valley Fever Medication Product Offerings
Table 56. Lunan Pharmaceutical Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 57. Yi Kang Pharm Corporate Summary
Table 58. Yi Kang Pharm Valley Fever Medication Product Offerings
Table 59. Yi Kang Pharm Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 60. Kelun Corporate Summary
Table 61. Kelun Valley Fever Medication Product Offerings
Table 62. Kelun Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 63. ShiJiaZhuang No.4 Pharmaceutical Corporate Summary
Table 64. ShiJiaZhuang No.4 Pharmaceutical Valley Fever Medication Product Offerings
Table 65. ShiJiaZhuang No.4 Pharmaceutical Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 66. Qilu Pharmaceutical Group Corporate Summary
Table 67. Qilu Pharmaceutical Group Valley Fever Medication Product Offerings
Table 68. Qilu Pharmaceutical Group Valley Fever Medication Revenue (US$, Mn), (2017-2022)
Table 69. Minsheng Pharmaceutical Corporate Summary
Table 70. Minsheng Pharmaceutical Valley Fever Medication Product Offerings
Table 71. Minsheng Pharmaceutical Valley Fever Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Valley Fever Medication Segment by Type in 2021
Figure 2. Valley Fever Medication Segment by Channel in 2021
Figure 3. Global Valley Fever Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Valley Fever Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Valley Fever Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Valley Fever Medication Revenue in 2021
Figure 8. By Type - Global Valley Fever Medication Revenue Market Share, 2017-2028
Figure 9. By Channel - Global Valley Fever Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global Valley Fever Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America Valley Fever Medication Revenue Market Share, 2017-2028
Figure 12. US Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Valley Fever Medication Revenue Market Share, 2017-2028
Figure 16. Germany Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Valley Fever Medication Revenue Market Share, 2017-2028
Figure 24. China Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Valley Fever Medication Revenue Market Share, 2017-2028
Figure 30. Brazil Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Valley Fever Medication Revenue Market Share, 2017-2028
Figure 33. Turkey Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Valley Fever Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceuticals Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Apotex Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi-Aventis Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hexal Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mylan Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Baxter Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lunan Pharmaceutical Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Yi Kang Pharm Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Kelun Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ShiJiaZhuang No.4 Pharmaceutical Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Qilu Pharmaceutical Group Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Minsheng Pharmaceutical Valley Fever Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)